JUDY CHAVA: Open Payments
NPI 1629556949 · CANTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,318 in 73 payments from 10 companies in 2025. Trend: 2023 $1,850 · 2024 $1,543 · 2025 $1,318
Food & beverage: $1,318
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $341 |
| E.R. Squibb & Sons, L.L.C. | 18 | $244 |
| Alkermes, Inc. | 7 | $188 |
| Teva Pharmaceuticals USA, Inc. | 4 | $149 |
| Otsuka America Pharmaceutical, Inc. | 3 | $143 |
| Neurocrine BioSciences, Inc. | 2 | $142 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $55 |
| Corium, LLC | 1 | $22 |
| Lundbeck LLC | 1 | $17 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
Products named: VRAYLAR, COBENFY, INGREZZA, AUSTEDO XR, REXULTI, LYBALVI, CAPLYTA, ARISTADA.
Industry payments across OH — which companies pay providers there.
